Search Results 141-150 of 18110 for CLL

  1. Hematology - Clinical trials

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

  2. Contact - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Contact Dr. Slager about her research on the genetic basis of chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis, or about enrolling in a ...

  3. Asher A. Chanan-Khan, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Asher A. Chanan-Khan, M.D., investigates treatments for chronic lymphocytic leukemia (CLL), Waldenstrom macroglobulinemia and ...

  4. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  5. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  6. Mazie Tsang, M.D. - Mayo Clinic Faculty Profiles

    Focus areas · Decision-making for older adults with advanced cancers. Dr. · Managing older adults with chronic lymphocytic leukemia (CLL). CLL mainly affects ...

  7. Asher A. Chanan-Khan, M.D. - Doctors and Medical Staff - Mayo Clinic

    Chronic lymphocytic leukemia (CLL); Waldenstroms macroglobulinemia; Experimental therapeutics; Drug resistance in multiple myeloma; Novel therapeutics in ...

  8. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  9. A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT) - Mayo Clinic

    A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT). Print details. Share; Facebook ...

  10. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

    This phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with ...